Tanabe Pharma America Completes Transfer of RADICAVA Business to Shionogi Tanabe Pharma America finalizes the transfer of RADICAVA to Shionogi, ensuring the therapy's continued growth and support for ALS patients.

Tanabe Pharma America Completes Transfer of RADICAVA Business to Shionogi #USA #Jersey_City #RADICAVA #Shionogi #Tanabe_Pharma

Apnimed Sells Joint Venture Stake for $150 Million to Focus on AD109 Development Apnimed has sold its stake in a joint venture with Shionogi for $150M, strengthening its focus on the development of AD109 for obstructive sleep apnea.

Apnimed Sells Joint Venture Stake for $150 Million to Focus on AD109 Development #USA #Cambridge #Apnimed #AD109 #Shionogi

Shionogi Healthcare Unveils New Cough Suppressant Tablet for Ages 8 and Up Shionogi Healthcare introduces ASVERIN® Cough Suppressant Pro20, designed for ages 8 and older, expanding self-medication options with advanced efficacy.

Shionogi Healthcare Unveils New Cough Suppressant Tablet for Ages 8 and Up #Japan #Osaka #Shionogi #Self-Medication #Asverin

Hitachi Collaborates with Shionogi to Utilize Generative AI for Regulatory Document Creation in Pharmaceuticals Hitachi and Shionogi collaborate to boost pharmaceutical R&D efficiency through AI-enhanced regulatory documentation solutions, starting in 2026.

Hitachi Collaborates with Shionogi to Utilize Generative AI for Regulatory Document Creation in Pharmaceuticals #Japan #Generative_AI #Tokyo #Hitachi #Shionogi

Cumulus Neuroscience Expands its Vision into the Japanese Market Through Collaboration with Shionogi & Co., Ltd. Cumulus Neuroscience enters the Japanese market through a partnership with Shionogi, aiming to enhance cognitive biomarker research for innovative therapies.

Cumulus Neuroscience Expands its Vision into the Japanese Market Through Collaboration with Shionogi & Co., Ltd. #Japan #Osaka #Cumulus_Neuroscience #Shionogi #NeuLogiq_Platform

ViiV ownership shifts as Pfizer sells its stake Pfizer will relinquish its stake in HIV firm ViiV in a deal valued at $2.1bn that ramps up Shionogi's interest and simplifies its share structure

#ViiV #Pfizer #ViiVHealthcare #Shionogi #HIV #GSK #strategicpartnership #jointventure #HIVtherapies #GileadSciences #HIVtreatment #antiretroviraltherapy #longeractinginjectableregimens #HIVpreexposureprophylaxis #PrEP #preexposureprophylaxis #Apretude #cabotegravir #lenacapavir
zurl.co/khJ6D

Shionogi Healthcare Receives Approval for OTC Cough Relief Product Asverin® Shionogi Healthcare has announced the approval of its new OTC cough syrup, Asverin® Cough Relief Pro20, promising effective relief for all ages.

Shionogi Healthcare Receives Approval for OTC Cough Relief Product Asverin® #Japan #Osaka #Shionogi #Asverin #OTC_Cough_Relief

Tanabe Pharma America Transfers RADICAVA® Business to Shionogi for Growth and Innovation Tanabe Pharma America has announced the transfer of RADICAVA® business to Shionogi, aiming for enhanced focus on growth and solutions for ALS patients.

Tanabe Pharma America Transfers RADICAVA® Business to Shionogi for Growth and Innovation #United_States #Jersey_City #RADICAVA #Shionogi #Tanabe_Pharma

Apnimed Set to Present at the 5th Annual Needham Virtual Biotech Forum Apnimed, Inc. will participate in the Needham Private Biotech and MedTech Forum, showcasing its innovative oral treatments for sleep apnea.

Apnimed Set to Present at the 5th Annual Needham Virtual Biotech Forum #USA #Cambridge #Apnimed #OSA #Shionogi

Introducing the New Iodine Clear Gargle: A Convenient and Effective Gargle Solution The new Iodine Clear Gargle from Shionogi Healthcare offers an easy-to-use, effective solution for throat care with a 400mL capacity.

Introducing the New Iodine Clear Gargle: A Convenient and Effective Gargle Solution #Japan #Osaka #Shionogi #iodine #Gargle

Respiratory Weekly News – July 4th 2025 Lung & Respiratory Breakthroughs: ALYFTREK Approval, IPF Trial Milestones, PAH Advancements and more   This week on Lung and Respiratory […] The post Respiratory Weekly News – July 4th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Respiratory Weekly News – July 4th 2025 #News #biotech #Shionogi #cysticfibrosis #BioVersys Comment below!

Shionogi Enhances Data Management with Stibo Systems MDM Solution Implementation Shionogi & Co., Ltd. has successfully implemented Stibo Systems' MDM technology, aiming to enhance its data management framework and support digital transformation efforts.

Shionogi Enhances Data Management with Stibo Systems MDM Solution Implementation #Japan #Osaka #Stibo_Systems #Hitachi #Shionogi

Respiratory Weekly News – July 4th 2025 Lung & Respiratory Breakthroughs: ALYFTREK Approval, IPF Trial Milestones, PAH Advancements and more   This week on Lung and Respiratory […] The post Respiratory Weekly News – July 4th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Respiratory Weekly News – July 4th 2025 #News #biotech #Shionogi #cysticfibrosis #BioVersys Comment below!

Respiratory Weekly News – July 4th 2025 Lung & Respiratory Breakthroughs: ALYFTREK Approval, IPF Trial Milestones, PAH Advancements and more   This week on Lung and Respiratory […] The post Respiratory Weekly News – July 4th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Respiratory Weekly News – July 4th 2025 #News #biotech #Shionogi #cysticfibrosis #BioVersys Comment below!

Japan's #Shionogi has added to its #antibiotics pipeline by partnering a preclinical-stage candidate from Swiss #biotech #BioVersys, which specialises in drugs that can counter antimicrobial resistance (#AMR).

pharmaphorum.com/news/shionog...

Exploring the Transformation of Healthcare into a Service Model by Shionogi Pharmaceutical Join the upcoming seminar hosted by JPI featuring Dr. Hiroyuki Kobayashi from Shionogi, who will discuss the 'Healthcare as a Service' strategy and its implications for the future of healthcare.

Exploring the Transformation of Healthcare into a Service Model by Shionogi Pharmaceutical #Japan #Tokyo #JPI_Seminar #Shionogi #Healthcare_as_a_Service

Shionogi Pharmaceuticals Improves Procurement with Coupa and TechTouch Integration Shionogi Pharmaceuticals adopts TechTouch to enhance procurement efficiency on the Coupa platform, aiming for smoother operations and lower costs.

Shionogi Pharmaceuticals Improves Procurement with Coupa and TechTouch Integration #Japan #Osaka #Coupa #Shionogi #TechTouch

Nxera and Shionogi Deliver Innovation with QUVIVIQ™ Launch, Targeting Japan's Insomnia Epidemic Nxera Pharma Co., Ltd.

www.linkedin.com/pulse/nxera-...

Nxera and Shionogi Deliver Innovation with QUVIVIQ™ Launch, Targeting Japan's Insomnia Epidemic

kstrategyand.com/pharma-news

#NxeraPharma #Shionogi #QUVIVIQ #Daridorexant #InsomniaTreatment #SleepHealth #MentalHealthSupport #Humanteconomy #Humantec